Krystal Biotech ($KRYS)

Description

Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors for serious or rare diseases.

Krystal Biotech ($KRYS) is located in the Pittsburgh ecosystem.

Related

• Ionis Pharmaceuticals ($IONS)Develops RNA- and DNA-targeted medicines for people with serious diseases, with marketed therapies including TEGSEDI and WAYLIVRA for…
• Beam Therapeutics ($BEAM)Develops investigational base-editing genetic medicines and delivery technologies, including electroporation, nonviral, and viral methods,…
• Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…
• Moderna ($MRNA)Develops mRNA medicines using a platform for designing, researching, and testing mRNA, with a focus on addressing infectious and serious…
• Vertex Pharmaceuticals ($VRTX)Discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about…
• Capsida BiotherapeuticsDevelops targeted genetic medicines and engineered capsids for neurological and ocular diseases, including IV-delivered CNS gene therapies…
• Vertex Pharmaceuticals (San Diego)Discovers, develops, and produces medicines for serious diseases, while providing medical information, patient support, and clinical trial…
• Arbor BiotechnologiesDevelops gene editing treatments and genetic medicines using programmable DNA editors for people with genetic diseases, with a focus on CNS…
• Poseida Therapeutics (Roche)Develops cell therapy candidates and related platform technologies, with legacy programs in a biotechnology pipeline for medicines…
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision…
• TGen (Translational Genomics Research Institute)Studies genetic factors in cancer, neurological conditions, infectious diseases, and rare childhood disorders, recruiting healthy and…
• BioCryst Pharmaceuticals ($BCRX)Develops oral small-molecule and injectable protein medicines for hereditary angioedema and other rare diseases, with physician-requested…